Literature DB >> 33511957

The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Atherosclerosis.

Vyacheslav Ogay1, Aliya Sekenova1, Yelena Li2, Assel Issabekova2, Arman Saparov3.   

Abstract

Atherosclerosis is a multifactorial and complex disease involving the arterial intima of the circulatory system. The main risk factors of atherosclerosis are diabetes mellitus, hypertension, hyperlipidemic states, smoking, mental stress, unhealthy diet and a lack of physical activity. Recent studies have shown that dyslipidemia, inflammation and immune cells are involved in all stages of development of atherosclerosis. Mesenchymal stem cells are a heterogeneous subset of multipotent cells that can be isolated from nearly all human organs and tissues, and they possess both regenerative and immunomodulatory properties. Recent studies have shown that mesenchymal stem cells are able to provide immunosuppressive, regenerative and atheroprotective effects by reducing dyslipidemia, inflammation, and inhibiting endothelial cell dysfunction and plaque formation during the development of atherosclerosis in animal models. Based on these beneficial effects, mesenchymal stem cells are considered a promising alternative therapeutic approach for effective treatment of atherosclerosis. In this review, we summarize the current findings on potential applications of mesenchymal stem cells for preventing and regressing atherosclerosis as well as discuss strategies for improving the efficacy of mesenchymal stem cell-based therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Mesenchymal stem cells; atherosclerosis; autophagy.; genetic modification; mesenchymal stem cell-based therapy; preconditioning

Year:  2021        PMID: 33511957     DOI: 10.2174/1574888X16999210128193549

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  4 in total

1.  Human Placental Mesenchymal Stem/Stromal cells (pMSCs) inhibit agonist-induced platelet functions reducing atherosclerosis and thrombosis phenotypes.

Authors:  Abdullah Al Subayyil; Yasser S Basmaeil; Reem Alenzi; Tanvir Khatlani
Journal:  J Cell Mol Med       Date:  2021-09-18       Impact factor: 5.310

Review 2.  Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis.

Authors:  Madina Sarsenova; Assel Issabekova; Saule Abisheva; Kristina Rutskaya-Moroshan; Vyacheslav Ogay; Arman Saparov
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

3.  Efficacy of Human Adipose Derived Mesenchymal Stem Cells in Promoting Skin Wound Healing.

Authors:  Lingcong Zhou; Hui Wang; Sidi Yao; Li Li; Xin Kuang
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

Review 4.  Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells.

Authors:  Madina Sarsenova; Yevgeniy Kim; Kamila Raziyeva; Bexultan Kazybay; Vyacheslav Ogay; Arman Saparov
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.